Abnova (Taiwan) Corporation

Short Term Long Term Short Term Comparison Long Term Comparison
  • 4133
  • 1d-1.27%
  • 1w-1.89%
  • 1m-1.11%
  • 1y-16.38%
ATH
  • ATH Price$149.53
  • ATH Date2020-07-09
  • % since ATH-79.17%
  • % to ATH380.02%
ATL
  • ATL Price$15.41
  • ATL Date2008-12-30
  • % from ATL102.19%
  • Last Low Price$31.1
  • Last Low Date2023-09-21
  • % From Last Low0.16%
IPO
  • IPO Price$52.16
  • % Current ROI USD-40.28%
  • ATH Price$149.53
  • % ROI ATH 97,053.19%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="4133"]

Key Data [addtoany]

Current price $31.15
Sector Healthcare
Industry Biotechnology
Today's High/Low $31.55/$31.15
Volume 99,662.00
Previous Close $31.55
52 Week High/Low $38.85/$30.95
Market Cap 1,910,478,592.00
P/E Ratio 43.8194
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0254
$31.15
[addtoany]

Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. It offers DNA and RNA, proteins/peptides, SARS-CoV/CoV-2,beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, circulating rare cells, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics.
The company also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, and IHC/pathology antibodies.
In addition, the company’s integrated solutions and services include gene synthesis and cytogenetics; peptide, protein expression, and conjugations; antibody production; and assay development services.
Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.

Annual Data | Millions of US $ except per share data 2019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Cash on hand ------------
Receivables $61.55$79.43$94.51$64.02$63.56$57.96$61.63$77.86$68.94$55.96$62.99$40.40
Inventory $458.78$494.69$567.58$581.24$596.63$611.32$586.10$576.57$550.99$527.46$471.04$400
Pre-Paid Expenses ------------
Other Current Assets $0.14$0.24$2.05$0.15$10.83$4.69$4.97$50.54$59.43$31.54$22.76$15.22
Total Current Assets $703.31$736.03$869.69$886.31$961.75$1,177.50$1,144.96-----
Property, Plant, And Equipment $330.23$342.64$292.76$225.87$173.26$44.04$50.43$50.32$66.54$60.43$81.78$105.23
Long-Term Investments $44.51$43.06$28.15$18.80--------
Goodwill And Intangible Assets ------------
Other Long-Term Assets $129.18$122.71$108.22$110.84$111.02$81.44$82.72$8.62$8.63$36.34$7.42$6.64
Total Long-Term Assets $560.68$558.97$434.09$361.96--------
Total Assets $1,263.99$1,295$1,303.78$1,248.28$1,248.98$1,307.88$1,285.18$1,292.06$1,355.18$1,334.14$1,305.52$857.02
Total Current Liabilities $64.30$66.74$77.82$71.02$82.14$78.15$55.42$63.12$84.17$63.28$93.08$108.88
Long Term Debt $0.47$0.35$0.29$0.51--------
Other Non-Current Liabilities $0.47$0.67$0.94$0.52$0.21$0500000--$0.34$0.96$2.27$3.83
Total Long Term Liabilities $7.29$1.03$1.23$1.04--------
Total Liabilities $71.59$67.77$79.05$72.06$82.35$78.15$55.42$63.12$84.51$64.24$95.34$112.71
Common Stock Net $605.54$605.54$605.54$587.90$580.47$595.47$595.47$595.47$595.47$595.47$595.47$541.58
Retained Earnings (Accumulated Deficit) $19.53$53.11$62.76$54.43$82.81$118.36$118.39$80.73$134.97$149.10$99.56-
Comprehensive Income ------------
Other Share Holders Equity $14.07$15.03$-4.91$-3.74$0.96$0.53$0.53-----
Share Holder Equity $1,192.40$1,227.23$1,224.73$1,176.22$1,166.63$1,229.72$1,229.76$1,228.94$1,270.67$1,269.90$1,210.17$744.31
Total Liabilities And Share Holders Equity ------------